Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eslicarbazepine acetate for fibromyalgia
NL-OMON24699Recruiting
- Sponsor
- BIAL
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of eslicarbazepine acetate in fibromyalgia (FM) (4 arms), sponsored by BIAL. Primary endpoint: Change in mean pain from baseline to endpoint. Started Apr 2009; status: recruiting.
02
Drugs
eslicarbazepine acetate
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NL-OMON24699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24699.